Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03312764 · ClinicalTrials.gov registry record · NA
Preventing Diabetes With Digital Health and Coaching
A NA study, sponsored by Omada Health.
- Completed
- Registry status
- NA
- Development phase
- 598
- Enrollment target
NCT03312764: Completed NA study, sponsored by Omada Health.
NCT03312764 is a NA study that has completed, run by Omada Health. The registered enrollment target is 598 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03312764, a NA study, has completed, sponsored by Omada Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 598 participants
- Enrollment target
Study Summary
The goal of this randomized controlled trial is to determine the efficacy of a digital diabetes prevention program for improving weight, glucose control, and secondary risk factors among people with prediabetes compared to an enhanced standard care plus wait-list control. Exploratory assessments of implementation facilitators and barriers will also be completed to determine strategies for integrating external diabetes-prevention interventions within healthcare settings.
Primary Outcome
Change in percent HbA1c
Interventions
- BEHAVIORAL Standard Care
- BEHAVIORAL Online diabetes prevention program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 598 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2020-08-31 |
| Phase | NA |
What the finished NCT03312764 record still lists
NCT03312764 is an interventional study that assigns participants to a tested intervention. The registered 598 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard Care is the first listed.
NCT03312764 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03312764 about?
NCT03312764 is a clinical study titled "Preventing Diabetes With Digital Health and Coaching". The goal of this randomized controlled trial is to determine the efficacy of a digital diabetes prevention program for improving weight, glucose control, and secondary risk factors among people with prediabetes compared to an enhanced standard care plus wait-list control. Exploratory assessments of ...
What is the current status of trial NCT03312764?
This trial is currently completed. It is a NA study. The enrollment target is 598 participants. The study started on 2017-11-01. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT03312764?
The interventions under investigation include: Standard Care (BEHAVIORAL), Online diabetes prevention program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03312764?
This trial is sponsored by Omada Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03312764's enrollment target sits among peer trials
598 174th of 2000 higher than 1,827 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06875973 · 599 participants · Phase 3
Pelacarsen Roll-over Extension Program
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI